{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:58:29Z","timestamp":1793278709087,"version":"4.5.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jconrel.2022.07.018","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T05:49:30Z","timestamp":1658468970000},"page":"592-605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment"],"prefix":"10.1016","volume":"349","author":[{"given":"Tang","family":"Hailing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Yonghong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yufeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Haitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jconrel.2022.07.018_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2022.07.018_bb0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41577-021-00539-6","article-title":"Cellular networks controlling T cell persistence in adoptive cell therapy","volume":"21","author":"Chan","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2022.07.018_bb0015","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","article-title":"Obstacles and opportunities in a forward vision for cancer nanomedicine","volume":"20","author":"de L\u00e1zaro","year":"2021","journal-title":"Nat. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2022.07.018_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112908","article-title":"Novel peptide therapeutic approaches for cancer treatment","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"issue":"19","key":"10.1016\/j.jconrel.2022.07.018_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26196042","article-title":"Progress and future directions with peptide-drug conjugates for targeted cancer therapy","volume":"26","author":"Lindberg","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.018_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030323","article-title":"Traditional and computational screening of non-toxic peptides and approaches to improving selectivity","volume":"15","author":"Robles-Loaiza","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.018_bb0035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"issue":"7873","key":"10.1016\/j.jconrel.2022.07.018_bb0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.jconrel.2022.07.018_bb0045","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00418-008-0401-3","article-title":"Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer","volume":"129","author":"Roepstorff","year":"2008","journal-title":"Histochem. Cell Biol."},{"issue":"11","key":"10.1016\/j.jconrel.2022.07.018_bb0055","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.3390\/cells10113244","article-title":"Quantification of EGFR-HER2 heterodimers in HER2-overexpressing breast cancer cells using liquid-phase electron microscopy","volume":"10","author":"Peckys","year":"2021","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.jconrel.2022.07.018_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216677","article-title":"Globally approved EGFR inhibitors: insights into their syntheses, target kinases, biological activities, receptor interactions, and metabolism","volume":"26","author":"Abourehab","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(03)00047-9","article-title":"EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization","volume":"11","author":"Ferguson","year":"2003","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.018_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.cell.2017.09.017","article-title":"EGFR ligands differentially stabilize receptor dimers to specify signaling kinetics","volume":"171","author":"Freed","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.018_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","article-title":"Structural basis for inhibition of the epidermal growth factor receptor by cetuximab","volume":"7","author":"Li","year":"2005","journal-title":"Cancer Cell"},{"issue":"45","key":"10.1016\/j.jconrel.2022.07.018_bb0080","doi-asserted-by":"crossref","first-page":"16650","DOI":"10.1074\/jbc.RA118.006961","article-title":"Epidermal growth factor (EGF) triggers nuclear calcium signaling through the intranuclear phospholipase C\u03b4-4 (PLC\u03b44)","volume":"294","author":"de Miranda","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.018_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11523-014-0344-7","article-title":"Afatinib resistance in non-small cell lung cancer involves the PI3K\/AKT and MAPK\/ERK signalling pathways and epithelial-to-mesenchymal transition","volume":"10","author":"Coco","year":"2014","journal-title":"Target. Oncol."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.018_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1251-7","article-title":"Ivermectin reverses the drug resistance in cancer cells through EGFR\/ERK\/Akt\/NF-\u03baB pathway","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.jconrel.2022.07.018_bb0100","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1158\/0008-5472.CAN-21-0556","article-title":"Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib","volume":"81","author":"Zhu","year":"2021","journal-title":"Cancer Res."},{"issue":"D1","key":"10.1016\/j.jconrel.2022.07.018_bb0105","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(03)00047-9","article-title":"EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization","volume":"11","author":"Ferguson","year":"2003","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.str.2007.11.009","article-title":"Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8","volume":"16","author":"Li","year":"2008","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.str.2011.11.016","article-title":"Structures of adnectin\/protein complexes reveal an expanded binding footprint","volume":"20","author":"Ramamurthy","year":"2012","journal-title":"Structure"},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.018_bb0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.str.2013.05.008","article-title":"Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies\/VHH Domains","volume":"21","author":"Schmitz","year":"2013","journal-title":"Structure"},{"issue":"41","key":"10.1016\/j.jconrel.2022.07.018_bb0130","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1002\/anie.201505964","article-title":"Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy","volume":"54","author":"Lee","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0135","article-title":"Cell-free synthesis of functional antibody fragments to provide a structural basis for antibody\u2013antigen interaction","volume":"13","author":"Pizzo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(02)00963-7","article-title":"Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains","volume":"110","author":"Ogiso","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0145","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(02)00940-6","article-title":"Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor \u03b1","volume":"110","author":"Garrett","year":"2002","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.jconrel.2022.07.018_bb0150","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1128\/MCB.00742-10","article-title":"Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor","volume":"30","author":"Lu","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0155","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1096\/fj.08-117002","article-title":"Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo","volume":"23","author":"Song","year":"2009","journal-title":"FASEB J."},{"issue":"14","key":"10.1016\/j.jconrel.2022.07.018_bb0160","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1096\/fj.05-4058com","article-title":"Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.018_bb0165","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1021\/acs.molpharmaceut.1c00918","article-title":"Biodistribution and activity of EGFR targeted polymeric micelles delivering a new inhibitor of DNA repair to orthotopic colorectal cancer xenografts with metastasis","volume":"19","author":"de Paiva","year":"2022","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.jconrel.2022.07.018_bb0170","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00726-018-2616-5","article-title":"Exploring pitfalls of 64Cu-labeled EGFR-targeting peptide GE11 as a potential PET tracer","volume":"50","author":"Striese","year":"2018","journal-title":"Amino Acids"},{"issue":"23","key":"10.1016\/j.jconrel.2022.07.018_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700596","article-title":"Enhanced EGFR targeting activity of plasmonic nanostructures with engineered GE11 peptide","volume":"6","author":"Biscaglia","year":"2017","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.018_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010002","article-title":"GE11 peptide as an active targeting agent in antitumor therapy: A Minireview","volume":"10","author":"Genta","year":"2017","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.jconrel.2022.07.018_bb0185","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/mp5001718","article-title":"Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumor","volume":"11","author":"Tang","year":"2014","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.018_bb0190","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/nl300395q","article-title":"Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand","volume":"12","author":"Mickler","year":"2012","journal-title":"Nano Lett."},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.018_bb0195","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/mt.2010.296","article-title":"Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene","volume":"19","author":"Klutz","year":"2011","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2022.07.018_bb0200","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1089\/hum.2010.231","article-title":"Disconnecting the Yin and Yang Relation of Epidermal Growth Factor Receptor (EGFR)-Mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation","volume":"22","author":"Sch\u00e4fer","year":"2011","journal-title":"Hum. Gene Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2022.07.018_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-015-0624-9","article-title":"Peptide GE11\u2013Polyethylene Glycol\u2013Polyethylenimine for targeted gene delivery in laryngeal cancer","volume":"32","author":"Ren","year":"2015","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.018_bb0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/iub.1002","article-title":"PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors","volume":"64","author":"Abourbeh","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118898","article-title":"Multi-functional self-assembled nanoparticles for pVEGF-shRNA loading and anti-tumor targeted therapy","volume":"575","author":"Lu","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0220","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jps.24194","article-title":"Dual-targeted polyplexes based on sequence-defined peptide-PEG-oligoamino amides","volume":"104","author":"Kos","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"7\u20138","key":"10.1016\/j.jconrel.2022.07.018_bb0225","article-title":"Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery","volume":"20","author":"Steinborn","year":"2018","journal-title":"J. Gene Med."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.07.018_bb0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2008.07.012","article-title":"Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo","volume":"363","author":"Song","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2022.07.018_bb0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.apsb.2019.06.011","article-title":"Reimaging biological barriers affecting distribution and extravasation of PEG\/peptide- modified liposomes in xenograft SMMC7721 tumor","volume":"10","author":"Tang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/7832216","article-title":"GE11 peptide conjugated liposomes for EGFR-targeted and chemophotothermal combined anticancer therapy","volume":"2021","author":"Huang","year":"2021","journal-title":"Bioinorg. Chem. Appl."},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.018_bb0245","first-page":"1635","article-title":"Enhanced antiproliferative effect of resveratrol in head and neck squamous cell carcinoma using GE11 peptide conjugated liposome","volume":"43","author":"Zheng","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0250","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.colsurfb.2016.06.012","article-title":"EGFR targeted thermosensitive liposomes: A novel multifunctional platform for simultaneous tumor targeted and stimulus responsive drug delivery","volume":"146","author":"Haeri","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0255","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.2147\/IJN.S129946","article-title":"GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers","volume":"12","author":"Xu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.018_bb0260","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2147\/IJN.S53310","article-title":"GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation","volume":"9","author":"Chen","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0265","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.biopha.2015.01.027","article-title":"Design and biological activity of epidermal growth factor receptor-targeted peptide doxorubicin conjugate","volume":"70","author":"Fan","year":"2015","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051113","article-title":"Synthesis, microtubule-binding affinity, and antiproliferative activity of new epothilone analogs and of an EGFR-targeted epothilone-peptide conjugate","volume":"20","author":"Gaugaz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.dyepig.2018.11.055","article-title":"Synthesis and biological evaluation of phthalocyanine-peptide conjugate for EGFR-targeted photodynamic therapy and bioimaging","volume":"163","author":"Yu","year":"2019","journal-title":"Dyes Pigments"},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.018_bb0280","article-title":"99mTc-radiolabeled GE11-modified peptide for ovarian tumor targeting","volume":"25","author":"Rahmanian","year":"2017","journal-title":"DARU J. Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1874471011205010015","article-title":"Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET Imaging of EGFR-Rich Tumors","volume":"5","author":"DeJesus","year":"2012","journal-title":"Curr. Radiopharm."},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.018_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040196","article-title":"Modulation of hypoxia-induced chemoresistance to polymeric micellar cisplatin: the effect of ligand modification of micellar carrier versus inhibition of the mediators of drug resistance","volume":"10","author":"Soleymani Abyaneh","year":"2018","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/1061186X.2015.1058800","article-title":"Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery","volume":"24","author":"Fan","year":"2015","journal-title":"J. Drug Target."},{"issue":"11","key":"10.1016\/j.jconrel.2022.07.018_bb0300","doi-asserted-by":"crossref","first-page":"10785","DOI":"10.1021\/acsnano.8b01573","article-title":"Epidermal growth factor receptor-targeting peptide nanoparticles simultaneously deliver gemcitabine and olaparib to treat pancreatic cancer with breast cancer 2 (BRCA2) mutation","volume":"12","author":"Du","year":"2018","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.018_bb0305","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-015-3132-0","article-title":"Peptide-conjugated micelles as a targeting nanocarrier for gene delivery","volume":"17","author":"Lin","year":"2015","journal-title":"J. Nanopart. Res."},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0310","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1021\/acs.molpharmaceut.9b01043","article-title":"Synthesis and analysis of 64Cu-labeled GE11-Modified polymeric micellar nanoparticles for EGFR-targeted molecular imaging in a colorectal cancer model","volume":"17","author":"Paiva","year":"2020","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.jconrel.2022.07.018_bb0315","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/1061186X.2011.632011","article-title":"Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer","volume":"19","author":"Kopansky","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2016.05.041","article-title":"Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer","volume":"101","author":"Brinkman","year":"2016","journal-title":"Biomaterials"},{"issue":"50","key":"10.1016\/j.jconrel.2022.07.018_bb0325","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.1021\/acs.langmuir.8b02946","article-title":"Distinction between active and passive targeting of nanoparticles dictate their overall therapeutic efficacy","volume":"34","author":"Clemons","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0330","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.2147\/IJN.S113469","article-title":"GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy","volume":"11","author":"Hu","year":"2016","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.jconrel.2022.07.018_bb0335","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-008-9065-0","article-title":"Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells","volume":"10","author":"Magadala","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0340","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.biopha.2016.12.138","article-title":"Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer","volume":"88","author":"Yan","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.018_bb0345","article-title":"Therapeutic efficacy and safety of paclitaxel\/lonidamine loaded EGFR-targeted nanoparticles for the treatment of multi-drug resistant cancer","volume":"6","author":"Fatouros","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jconrel.2022.07.018_bb0350","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ijpharm.2016.08.011","article-title":"Design of smart GE11-PLGA\/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro\/ex vivo characterization","volume":"511","author":"Colzani","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"16","key":"10.1016\/j.jconrel.2022.07.018_bb0355","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1021\/acsomega.9b02086","article-title":"Real-time label-free targeting assessment and in vitro characterization of curcumin-loaded poly-lactic-co-glycolic acid nanoparticles for oral colon targeting","volume":"4","author":"Akl","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0360","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211004954","article-title":"GE11 modified PLGA\/TPGS nanoparticles targeting delivery of salinomycin to breast cancer cells","volume":"20","author":"Li","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.018_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082304","article-title":"Intra-articular formulation of GE11-PLGA conjugate-based NPs for dexamethasone selective targeting\u2014in vitro evaluation","volume":"19","author":"Chiesa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0370","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.actbio.2020.06.020","article-title":"GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma","volume":"113","author":"Zhou","year":"2020","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.018_bb0375","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1021\/acs.molpharmaceut.8b00024","article-title":"GE11-directed functional polymersomal doxorubicin as an advanced alternative to clinical liposomal formulation for ovarian cancer treatment","volume":"15","author":"Zou","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0380","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.actbio.2017.10.013","article-title":"EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo","volume":"64","author":"Fang","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2017.01.042","article-title":"Tumor-targeted pH\/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery","volume":"259","author":"Chen","year":"2017","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0390","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1039\/C8BM01492B","article-title":"GE11-PDA-Pt@USPIOs nano-formulation for relief of tumor hypoxia and MRI\/PAI-guided tumor radio-chemotherapy","volume":"7","author":"Yang","year":"2019","journal-title":"Biomaterials Sci."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0395","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biomaterials.2015.12.015","article-title":"Development of self-assembling peptide nanovesicle with bilayers for enhanced EGFR-targeted drug and gene delivery","volume":"82","author":"Liang","year":"2016","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.jconrel.2022.07.018_bb0400","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1021\/acs.analchem.6b01443","article-title":"Construction of epidermal growth factor receptor peptide magnetic nanovesicles with lipid bilayers for enhanced capture of liver cancer circulating tumor cells","volume":"88","author":"Ding","year":"2016","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.018_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060505","article-title":"Particle-size-dependent delivery of antitumoral miRNA using targeted mesoporous silica nanoparticles","volume":"12","author":"Haddick","year":"2020","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/hum.2015.015","article-title":"Incorporation of peptides targeting EGFR and FGFR1 into the adenoviral fiber knob domain and their evaluation as targeted cancer therapies","volume":"26","author":"Uusi-Kerttula","year":"2015","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.018_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95891-x","article-title":"Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells","volume":"11","author":"Grataitong","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0420","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/157016311798109344","article-title":"Correlation of fixed aqueous layer thickness around peg-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes","volume":"8","author":"Sugiyama","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0425","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.colsurfb.2017.04.018","article-title":"Interaction between PEG lipid and DSPE\/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylation","volume":"155","author":"Paolino","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.018_bb0430","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1021\/jm201544y","article-title":"Phthalocyanine\u2013peptide conjugates for epidermal growth factor receptor targeting","volume":"55","author":"Ongarora","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2022.07.018_bb0435","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/acs.jctc.9b01208","article-title":"Comprehensive evaluation of fourteen docking programs on protein\u2013peptide complexes","volume":"16","author":"Weng","year":"2020","journal-title":"J. Chem. Theory Comput."},{"issue":"W1","key":"10.1016\/j.jconrel.2022.07.018_bb0440","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0445","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nucmedbio.2018.11.003","article-title":"68Ga-labelled NOTA-RGD-GE11 peptide for dual integrin and EGFR-targeted tumour imaging","volume":"68\u201369","author":"Chen","year":"2019","journal-title":"Nucl. Med. Biol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.07.018_bb0450","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2018.01.011","article-title":"Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability","volume":"538","author":"Xiao","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2022.07.018_bb0455","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cam4.3635","article-title":"Clathrin-mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild-type EGFR non-small cell lung cancer","volume":"10","author":"Kim","year":"2020","journal-title":"Cancer Med."},{"issue":"5","key":"10.1016\/j.jconrel.2022.07.018_bb0460","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1083\/jcb.200106056","article-title":"Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies","volume":"156","author":"Longva","year":"2002","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.018_bb0465","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1073\/pnas.0409817102","article-title":"Clathrin-independent endocytosis of ubiquitinated cargos","volume":"102","author":"Sigismund","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.018_bb0470","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2217\/nnm-2015-0009","article-title":"Cetuximab treatment alters the content of extracellular vesicles released from tumor cells","volume":"11","author":"van Dommelen","year":"2016","journal-title":"Nanomedicine (London)"},{"issue":"3\u20134","key":"10.1016\/j.jconrel.2022.07.018_bb0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41434-019-0059-6","article-title":"Dual-targeted NIS polyplexes\u2014a theranostic strategy toward tumors with heterogeneous receptor expression","volume":"26","author":"Urnauer","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2022.07.018_bb0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jconrel.2014.12.018","article-title":"Improving drug delivery to solid tumors: Priming the tumor microenvironment","volume":"201","author":"Khawar","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0485","first-page":"205","article-title":"A traceable, GSH\/pH dual-responsive nanoparticles with spatiotemporally controlled multiple drugs release ability to enhance antitumor efficacy","author":"Wang","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"9","key":"10.1016\/j.jconrel.2022.07.018_bb0490","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1021\/acs.molpharmaceut.1c00263","article-title":"Multifunctional traceable liposomes with temperature-triggered drug release and neovasculature-targeting properties for improved cancer chemotherapy","volume":"18","author":"Yuba","year":"2021","journal-title":"Mol. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2022.07.018_bb0495","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(94)90012-4","article-title":"Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications","volume":"174","author":"Van Rooijen","year":"1994","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.jconrel.2022.07.018_bb0500","doi-asserted-by":"crossref","first-page":"14779","DOI":"10.1021\/acsnano.0c02821","article-title":"Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0505","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.saa.2016.10.016","article-title":"Interaction of phospholipase C with liposome: A conformation transition of the enzyme is critical and specific to liposome composition for burst hydrolysis and fusion in concert","volume":"173","author":"Patra","year":"2017","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"8","key":"10.1016\/j.jconrel.2022.07.018_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/nano11081963","article-title":"Size-dependent internalization efficiency of macrophages from adsorbed nanoparticle-based monolayers","volume":"11","author":"Petithory","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2022.07.018_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106119","article-title":"New repurposed rolapitant in nanovesicular systems for lung cancer treatment: Development, in-vitro assessment and in-vivo biodistribution study","volume":"171","author":"Kabil","year":"2022","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200428X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200428X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:31:14Z","timestamp":1759163474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592200428X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":103,"alternative-id":["S016836592200428X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}